The Genome Editing/Genome Engineering Market is expected to grow from USD 4.50 billion in 2019 to USD 12.24 billion by 2026 at a CAGR of 15.37% from 2019 to 2026.
Genomic editing raises to the strategies and techniques applied for the modification of target genetic information of any living organism. Genome editing includes gene modification at specific areas through recombinant technology, which rises precision in insertion and decreases cell toxicity. Current advancement in genome editing is based on programmable nucleases. The market is now witnessing significant development owing to increase in R&D expenditure, rise in government funding for genomic research, technological advancements, and growth in production of genetically improved crops. Companies have made significant investments in R&D in the past few years to develop cutting-edge technologies, such as, CRISPR and TALEN. For instance, Thermo Fisher Scientific is investing significantly in the development of its CRISPR technology for providing better efficiency and accuracy in research and also to fulfil the unmet demands in research and therapeutics. Cas9 protein and FokI protein have been shared to form a dimeric CRISPR/Cas9 RNA-guided FokI nucleases system, which is expected to have wide range of genome editing applications. The market is increasing rapidly because of its application in a large number of areas, like mutation, therapeutics, and agriculture biotechnology. This techniques offer large opportunities in crop improvement. But the real potential of homologous recombination for crop improvement in besieged gene replacement therapy is yet to be realized.
The global market is segregated on the basis of Application as Genetic Engineering, Other Applications, and Cell Line Engineering. Based on End User the global market is segmented in Academic & Research Institutions, Contract Research Organization, and Biotechnology & Pharmaceutical Companies. Based on Technology the globalmarket is segmented in ZFN, Antisense, Other Technologies, CRISPR, and Talen.
The global Genome Editing/Genome Engineering market report provides geographic analysis covering regions, such as Europe, North America, Asia Pacific, and Rest of The World. The market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Integrated Dna Technologies, Lonza, New England Biolabs, Origene Technologies, Transposagen Biopharmaceuticals, Thermo Fisher Scientific, Merck, Horizon Discovery Group, Genscript, Sangamo Biosciences, and others are among the major players in the global market. The companies studied in terms of product strategy and various n several growth and expansion strategies to gain a competitive edge in the market. The major players not only follow value chain integration with business operations in multiple stages of the value chain.
The global Genome Editing/Genome Engineering market has been segmented as below:
By Application
By End User
By Technology
By Region
By Company
The report covers the below scope:
The years considered for the study are as follows:
Report Scope:
The global Genome Editing/Genome Engineering market report scope includes detailed study covering underlying factors influencing the industry trends. The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global market share. Major industry players with significant revenue share include Integrated Dna Technologies, Lonza, New England Biolabs, Origene Technologies, Transposagen Biopharmaceuticals, Thermo Fisher Scientific, Merck, Horizon Discovery Group, Genscript, Sangamo Biosciences, and others.
Why to Buy this Report:
Target Audience:
The report targeted towards the existing players in the industry is as follows:
Free and Paid Customization based on the requirement
Report Content
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach - Segmental Market Analysis
2.5.2 Top-Down Approach - Parent Market Analysis
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter''s Five Force Analysis
5.1 Introduction
5.2 Genetic Engineering
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Other Applications
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Cell Line Engineering
5.4.1 Market Overview
5.4.2 Market Size and Forecast
6.1 Introduction
6.2 Academic & Research Institutions
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Contract Research Organization
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Biotechnology & Pharmaceutical Companies
6.4.1 Market Overview
6.4.2 Market Size and Forecast
7.1 Introduction
7.2 ZFN
7.2.1 Market Overview
7.2.2 Market Size and Forecast
7.3 Antisense
7.3.1 Market Overview
7.3.2 Market Size and Forecast
7.4 Other Technologies
7.4.1 Market Overview
7.4.2 Market Size and Forecast
7.5 CRISPR
7.5.1 Market Overview
7.5.2 Market Size and Forecast
7.6 Talen
7.6.1 Market Overview
7.6.2 Market Size and Forecast
8.1 Introduction
8.2 Europe
8.2.1 Europe Market, By Application
8.2.2 Europe Market, By End User
8.2.3 Europe Market, By Technology
8.3 North America
8.3.1 North America Market, By Application
8.3.2 North America Market, By End User
8.3.3 North America Market, By Technology
8.4 Asia Pacific
8.4.1 Asia Pacific Market, By Application
8.4.2 Asia Pacific Market, By End User
8.4.3 Asia Pacific Market, By Technology
8.5 Rest of The World
8.5.1 Rest of The World Market, By Application
8.5.2 Rest of The World Market, By End User
8.5.3 Rest of The World Market, By Technology
9.1 Key Insights
9.2 Company Market Share Analysis
9.3 Strategic Outlook
9.3.1 Mergers & Acquisitions
9.3.2 New Product Development
9.3.3 Portfolio/Production Capacity Expansions
9.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
9.3.5 Others
10.1 Integrated Dna Technologies
10.1.1 Company Overview
10.1.2 Product/Service Landscape
10.1.3 Financial Overview
10.1.4 Recent Developments
10.2 Lonza
10.2.1 Company Overview
10.2.2 Product/Service Landscape
10.2.3 Financial Overview
10.2.4 Recent Developments
10.3 New England Biolabs
10.3.1 Company Overview
10.3.2 Product/Service Landscape
10.3.3 Financial Overview
10.3.4 Recent Developments
10.4 Origene Technologies
10.4.1 Company Overview
10.4.2 Product/Service Landscape
10.4.3 Financial Overview
10.4.4 Recent Developments
10.5 Transposagen Biopharmaceuticals
10.5.1 Company Overview
10.5.2 Product/Service Landscape
10.5.3 Financial Overview
10.5.4 Recent Developments
10.6 Thermo Fisher Scientific
10.6.1 Company Overview
10.6.2 Product/Service Landscape
10.6.3 Financial Overview
10.6.4 Recent Developments
10.7 Merck
10.7.1 Company Overview
10.7.2 Product/Service Landscape
10.7.3 Financial Overview
10.7.4 Recent Developments
10.8 Horizon Discovery Group
10.8.1 Company Overview
10.8.2 Product/Service Landscape
10.8.3 Financial Overview
10.8.4 Recent Developments
10.9 Genscript
10.9.1 Company Overview
10.9.2 Product/Service Landscape
10.9.3 Financial Overview
10.9.4 Recent Developments
10.10 Sangamo Biosciences
10.10.1 Company Overview
10.10.2 Product/Service Landscape
10.10.3 Financial Overview
10.10.4 Recent Developments
The global Genome Editing/Genome Engineering market has been segmented as below:
By Application
By End User
By Technology
By Region
By Company